Angina Market Key Players, Trends & Forecast to 2034

The Angina Market is experiencing steady growth worldwide as heart disease cases rise and healthcare providers adopt advanced diagnostic tools, novel anti-anginal medications, and cutting-edge interventional cardiology treatments. With precision diagnostics, long-acting drug therapies, and improved cardiac revascularization techniques, the market is set for substantial expansion through 2034.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/52004

1. What Is Angina? (Keyword Definition)
Angina pectoris-commonly known as angina-is chest pain or discomfort caused by insufficient blood flow to the heart muscle due to narrowed coronary arteries.

Types of Angina
• Stable Angina - Predictable pain during exertion; improves with rest
• Unstable Angina - Sudden chest pain; medical emergency
• Variant (Prinzmetal) Angina - Caused by coronary artery spasms
• Microvascular Angina - Due to dysfunction in tiny coronary vessels
Symptoms
• Chest pressure or tightness
• Pain radiating to arm, jaw, shoulder
• Fatigue & shortness of breath
• Nausea, dizziness

Diagnosis involves ECG, high-sensitivity troponin tests, exercise stress tests, echocardiography, CT coronary angiography, and, in acute cases, coronary catheterization.

2. Key Players in the Market
Leading companies providing cardiovascular drugs, diagnostics, and interventional devices include:
• AstraZeneca
• Pfizer Inc.
• Bayer AG
• Sanofi S.A.
• Merck & Co., Inc.
• Novartis AG
• AbbVie Inc.
• Gilead Sciences
• Medtronic plc
• Boston Scientific Corporation

These companies manufacture anti-anginal medications, antiplatelets, cholesterol-lowering drugs, stents, and cardiovascular diagnostic tools.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/52004/angina-market

3. Key Events in the Last 5 Years
Major developments shaping the angina market include:
• Adoption of high-sensitivity troponin assays improving diagnosis of unstable angina.
• Rapid advancements in PCI and stent technology, including next-gen drug-eluting stents.
• Growing use of CT coronary angiography for non-invasive evaluation of chest pain.
• Rise in long-acting anti-anginal therapies such as ranolazine and ivabradine.
• Improved cardiovascular preventive guidelines lowering long-term risks.
• Expansion of wearable health monitoring devices, including ECG patches and smartwatches.
• Post-COVID rise in cardiac complications, increasing need for cardiac imaging and angina management.

4. Market Growth Rate (CAGR & Forecast)
The Global Angina Market is projected to grow at a CAGR of 5%-7% between 2024 and 2034.
Growth Drivers
• Rising prevalence of coronary artery disease (CAD)
• Growing geriatric population
• Improved access to interventional cardiology
• Increasing use of advanced cardiac imaging
• Higher adoption of long-term preventive medications
• Expansion of cardiac rehabilitation programs
By 2034, the angina market is expected to become a multi-billion-dollar global industry.

5. Market Segments & Growth Analysis
By Type of Angina
• Stable Angina - Dominant segment due to chronic CAD
• Unstable Angina - Requires emergency treatment; high hospital utilization
• Variant Angina (Prinzmetal)
• Microvascular Angina

By Treatment Type
Medications
• Beta-blockers
• Calcium channel blockers
• Nitrates (short- & long-acting)
• Ranolazine (late sodium current inhibitor)
• Ivabradine (heart rate reduction agent)
• ACE inhibitors / ARBs
• Statins
• Antiplatelets - Aspirin, clopidogrel
Revascularization Procedures
• Percutaneous Coronary Intervention (PCI)
o Balloon angioplasty
o Drug-eluting stents
• Coronary Artery Bypass Grafting (CABG)
• Minimally invasive robotic-assisted procedures

By Diagnosis Method
• ECG & stress ECG
• High-sensitivity cardiac troponin testing
• Echocardiography
• Stress echocardiography
• CT Coronary Angiography (CTA)
• Coronary Angiogram - Gold standard
• Nuclear perfusion imaging

By End User
• Hospitals
• Cardiac Care Centers
• Diagnostic Imaging Centers
• Outpatient Clinics
• Ambulatory Surgical Centers

By Region
• North America - Largest share due to advanced cardiac care infrastructure
• Europe - Strong focus on preventive cardiology & CAD management
• Asia-Pacific - Fastest growth due to rising heart disease burden
• Latin America & MEA - Improving access to cardiac imaging and drug therapy

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=52004

6. Key Market Drivers
• Global rise in diabetes, obesity, and hypertension, the core risk factors for angina
• Increasing demand for minimally invasive cardiac intervention
• Growing popularity of CT-based non-invasive cardiac evaluation
• Rapid expansion of telecardiology and remote heart monitoring
• Wider availability of generic anti-anginal medications
• Strong government initiatives for cardiac screening and preventive care
• Breakthroughs in stent design, reducing restenosis rates

7. Conclusion
The Angina Market is set for strong and sustained growth over the next decade as global cardiovascular disease rates continue to rise. With advanced diagnostics-including high-sensitivity troponin tests and CT coronary angiography-combined with innovative anti-anginal drugs and minimally invasive procedures, patient outcomes are improving significantly.
Emerging technologies such as AI-based cardiac imaging, next-generation drug-eluting stents, and remote cardiac monitoring will further transform angina management. As healthcare systems increasingly focus on preventive cardiology and early detection, the angina market will expand rapidly through 2034, offering safer, faster, and more effective treatment pathways for millions of patients worldwide.

This report is also available in the following languages : Japanese (アンギナマーケット), Korean (협심증 시장), Chinese (安吉纳市场), French (Marché de l'angine), German (Angina-Markt), and Italian (Mercato dell'Angina), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/reports/52004/angina-market#request-a-sample

Our More Reports:

Retinal Vein Occlusion Market
https://exactitudeconsultancy.com/reports/72291/retinal-vein-occlusion-market

Mastitis Market
https://exactitudeconsultancy.com/reports/51962/mastitis-market

Moebius Syndrome Market
https://exactitudeconsultancy.com/reports/51964/moebius-syndrome-market

Mucormycosis Market
https://exactitudeconsultancy.com/reports/51966/mucormycosis-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.